Device Trial Radar · NCT06997003
Evaluation of a New Laser Refractive Vision Correction Using the TENEO™ 317 Model 2
Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
81
Planned (sponsor's estimate)
Start
Jun 16, 2025
Primary completion
May 2027
Study completion May 2027
Sponsor
- Lead sponsor
- Bausch & Lomb GmbHNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 30, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prospective, post market clinical follow up study with a three months postoperative follow up to evaluate the visual and refractive outcomes of OCTAVIUS treatment when used as intended.
Conditions
- Hyperopia and Myopia
Interventions
Anterior treatment modeDevice
Laser-in-situ-Keratomileusis (LASIK) surgery using OCTAVIUS treatment
Anterior treatment modeDevice
Laser-in-situ-Keratomileusis (LASIK) surgery using OCTAVIUS treatment
Total treatment modeDevice
Laser-in-situ-Keratomileusis (LASIK) surgery using OCTAVIUS treatment
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of eyes that achieve a Uncorrected Distance Visual Acuity of 20/40 or betterTime frame: Assessed for approximately 90 days
3 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Site 01
Zlín, Czech Republic, Czechia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.